Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10787054 | 0.85 | LMNA (0.58) | LMNAMAPK1CES2CES1CYP2D6 | |
| SCHEMBL26611026 | 0.84 | LMNA (0.52) | LMNAMAPK1CES2CES1CYP2D6 | |
| SCHEMBL821932 | 0.84 | LMNA (0.52) | LMNAMAPK1CES2CES1CYP2D6 | |
| SCHEMBL4297584 | 0.82 | MMP8 (0.57) | LMNAMAPK1CES2CES1SMN1; SMN2 | |
| SCHEMBL28289571 | 0.82 | LMNA (0.54) | LMNAMAPK1CES2CES1CYP2D6 | |
| SCHEMBL279960 | 0.82 | MMP8 (0.57) | LMNAMAPK1CES2CES1SMN1; SMN2 | |
| SCHEMBL1275430 | 0.82 | LMNA (0.54) | LMNAMAPK1CES2CES1CYP2D6 | |
| SCHEMBL3266292 | 0.82 | MMP8 (0.57) | LMNAMAPK1CES2CES1SMN1; SMN2 | |
| SCHEMBL27590464 | 0.82 | MMP8 (0.57) | LMNAMAPK1CES2CES1SMN1; SMN2 | |
| SCHEMBL27721038 | 0.81 | LMNA (0.48) | LMNAMAPK1CES2CES1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110157251-A | Curing agent composition and coating composition comprising it | ＫＣＣ公司 | 2019-08-23 | — | — | CN | disclosed |
| EP-0453504-B1 | DERIVATIVES OF HYDROXYMETHOXY MANDELIC ACID (HMMA), HOMOVANILLIC ACID (HVA), ANTIBODIES AND LABELLED SUBSTANCES PREPARED THEREFROM, AND IMMUNOASSAYS USING THESE | CANCER RES CAMPAIGN TECH (GB) | 1995-04-12 | — | — | EP | disclosed |
| EP-0453504-B1 | DERIVATIVES OF HYDROXYMETHOXY MANDELIC ACID (HMMA), HOMOVANILLIC ACID (HVA), ANTIBODIES AND LABELLED SUBSTANCES PREPARED THEREFROM, AND IMMUNOASSAYS USING THESE | CANCER RES CAMPAIGN TECH (GB) | 1995-04-12 | — | — | EP | disclosed |
| US-5373092-A | Derivatives of hydroxymethoxy mandelic acid (HMMA), homovanillic acid (HVA), antibodies and labelled substances prepared therefrom, and immunoassays using these | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1994-12-13 | — | — | US | disclosed |
| US-5373092-A | Derivatives of hydroxymethoxy mandelic acid (HMMA), homovanillic acid (HVA), antibodies and labelled substances prepared therefrom, and immunoassays using these | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1994-12-13 | — | — | US | disclosed |
| US-5373092-A | Derivatives of hydroxymethoxy mandelic acid (HMMA), homovanillic acid (HVA), antibodies and labelled substances prepared therefrom, and immunoassays using these | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1994-12-13 | — | — | US | disclosed |
| US-5266720-A | Labels for compounds | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1993-11-30 | — | — | US | disclosed |
| US-5266720-A | Labels for compounds | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1993-11-30 | — | — | US | disclosed |
| US-5266720-A | Labels for compounds | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1993-11-30 | — | — | US | disclosed |
| EP-0453504-A1 | DERIVATIVES OF HYDROXYMETHOXY MANDELIC ACID (HMMA), HOMOVANILLIC ACID (HVA), ANTIBODIES AND LABELLED SUBSTANCES PREPARED THEREFROM, AND IMMUNOASSAYS USING THESE. | CANCER RESEARCH CAMPAIGN (GB) | 1991-10-30 | — | — | EP | disclosed |
| EP-0453504-A1 | DERIVATIVES OF HYDROXYMETHOXY MANDELIC ACID (HMMA), HOMOVANILLIC ACID (HVA), ANTIBODIES AND LABELLED SUBSTANCES PREPARED THEREFROM, AND IMMUNOASSAYS USING THESE. | CANCER RESEARCH CAMPAIGN (GB) | 1991-10-30 | — | — | EP | disclosed |
| WO-1990008133-A1 | DERIVATIVES OF HYDROXYMETHOXY MANDELIC ACID (HMMA), HOMOVANILLIC ACID (HVA), ANTIBODIES AND LABELLED SUBSTANCES PREPARED THEREFROM, AND IMMUNOASSAYS USING THESE | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1990-07-26 | — | — | WO | disclosed |
| WO-1990008133-A1 | DERIVATIVES OF HYDROXYMETHOXY MANDELIC ACID (HMMA), HOMOVANILLIC ACID (HVA), ANTIBODIES AND LABELLED SUBSTANCES PREPARED THEREFROM, AND IMMUNOASSAYS USING THESE | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1990-07-26 | — | — | WO | disclosed |